Few in our industry would disagree with MIT’s Technology Review characterization of CRISPR/Cas9 as “the biggest biotech discovery of the century.” And yesterday’s revelation that Chinese scientists have already edited the genomes of human embryos has touched off yet another ethical debate as well as warnings that the findings show the technology is simply not […]
